Evidence for altered opioid activity in patients with cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1987-12

AUTHORS

P Lissoni, S Barni, F Paolorossi, S Crispino, F Rovelli, L Ferri, G Delitala, G Tancini

ABSTRACT

Endogenous opioid peptides have been shown to be involved in the regulation of tumour growth. At present, however, no data are available about the secretion of opioid peptides in cancer patients. To draw some preliminary conclusions on opioid brain function in human neoplasms, we evaluated hypophyseal hormone responses to the administration of a met-enkephalin analogue, FK 33-824. The study included 14 patients affected by early or advanced neoplastic disease, 12 healthy subjects and 7 patients with a chronic medical illness other than cancer. FK 33-824 was given intravenously at a dose of 0.3 mg. Venous blood samples were collected at zero time, and 30, 60 and 120 min after drug administration. In each sample, PRL, GH, LH, cortisol and beta-endorphin levels were measured by RIA. In all normal subjects and in patients with non-neoplastic chronic illness, FK 33-824 induced a rise in PRL and GH levels, and a decrease in LH, cortisol and beta-endorphin. A normal endocrine response to FK 33-824 was seen in our cancer patient only, while in the other cases with tumour no hormonal changes or a paradoxical response were seen after FK 33-824. Based on the fact that an abnormal endocrine response to FK 33-824 has been described in hypothalamic-pituitary disorders, in which anomalous brain opioid activity has been demonstrated, these results suggest the existence of an altered function of the opioid system in cancer patients, the clinical importance of which remains to be determined. More... »

PAGES

834

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1987.300

DOI

http://dx.doi.org/10.1038/bjc.1987.300

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015521315

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2963662


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "D-Ala(2),MePhe(4),Met(0)-ol-enkephalin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Growth Hormone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrocortisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Luteinizing Hormone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pituitary Gland", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prolactin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stimulation, Chemical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta-Endorphin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera San Gerardo", 
          "id": "https://www.grid.ac/institutes/grid.415025.7", 
          "name": [
            "Division of Radiation Oncology, Ospedale San Gerardo, Monza, Milan, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lissoni", 
        "givenName": "P", 
        "id": "sg:person.01217742247.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217742247.17"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Barni", 
        "givenName": "S", 
        "id": "sg:person.0645550356.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645550356.01"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Paolorossi", 
        "givenName": "F", 
        "id": "sg:person.01354712623.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354712623.20"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Crispino", 
        "givenName": "S", 
        "id": "sg:person.01365013037.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365013037.39"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Rovelli", 
        "givenName": "F", 
        "id": "sg:person.01123521022.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123521022.73"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ferri", 
        "givenName": "L", 
        "id": "sg:person.0670035541.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670035541.56"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Delitala", 
        "givenName": "G", 
        "id": "sg:person.01371224222.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371224222.07"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Tancini", 
        "givenName": "G", 
        "id": "sg:person.01352076635.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352076635.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0277-5379(85)90088-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008751506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0196-9781(83)90010-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012266972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000299028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015129013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0304-3835(83)90087-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018789955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(78)92100-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022386061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.1.6058.425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042830760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(83)90020-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048561010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(83)90020-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048561010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0361-9230(84)90164-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050077684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0361-9230(84)90164-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050077684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem-50-3-427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064310998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem-50-5-949", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064311117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089168607200410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079551885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089168607200410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079551885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081900399", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082321746", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1987-12", 
    "datePublishedReg": "1987-12-01", 
    "description": "Endogenous opioid peptides have been shown to be involved in the regulation of tumour growth. At present, however, no data are available about the secretion of opioid peptides in cancer patients. To draw some preliminary conclusions on opioid brain function in human neoplasms, we evaluated hypophyseal hormone responses to the administration of a met-enkephalin analogue, FK 33-824. The study included 14 patients affected by early or advanced neoplastic disease, 12 healthy subjects and 7 patients with a chronic medical illness other than cancer. FK 33-824 was given intravenously at a dose of 0.3 mg. Venous blood samples were collected at zero time, and 30, 60 and 120 min after drug administration. In each sample, PRL, GH, LH, cortisol and beta-endorphin levels were measured by RIA. In all normal subjects and in patients with non-neoplastic chronic illness, FK 33-824 induced a rise in PRL and GH levels, and a decrease in LH, cortisol and beta-endorphin. A normal endocrine response to FK 33-824 was seen in our cancer patient only, while in the other cases with tumour no hormonal changes or a paradoxical response were seen after FK 33-824. Based on the fact that an abnormal endocrine response to FK 33-824 has been described in hypothalamic-pituitary disorders, in which anomalous brain opioid activity has been demonstrated, these results suggest the existence of an altered function of the opioid system in cancer patients, the clinical importance of which remains to be determined.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1987.300", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "56"
      }
    ], 
    "name": "Evidence for altered opioid activity in patients with cancer", 
    "pagination": "834", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "49f379740d75e9b39f17586e1753886b389b79f81997af10445a2848227742d0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2963662"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1987.300"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015521315"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1987.300", 
      "https://app.dimensions.ai/details/publication/pub.1015521315"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc1987300"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1987.300'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1987.300'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1987.300'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1987.300'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      57 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1987.300 schema:about N06bace2e3b8c4059ae465d44047e53f9
2 N0c9d9cb934e94703ad624366911fdec1
3 N2fa76af3f3b44b75ac2ebd678bf80027
4 N3ba8780333544c559eaa89f0acb084d8
5 N4a95d42636904549a6fbca798f965787
6 N6ce9e2eac5fa443896bd906c0d635c6e
7 N8b47666b3bc34f23aec964c8bbfcbf34
8 N942ee4ccb919451aa6cc89ffb3ffbbb7
9 Na161c1c443984c6fa0f35d0977ea77ad
10 Nbf85ad1d145a40e1bbe04a2f827834bb
11 Nd45fcc03521347418b87794fb3bf41e0
12 Ned4209f040f345f58b920dabcd61d3b1
13 Nf248cbbd960544db8152db1ce33783c1
14 Nf6cbd0dbe252412aaf9aad22acad8625
15 Nf90a6769dcf649a0b20c0f990f8d5d1a
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author N80a3c84eee0e4e69a202ce7538a386f2
19 schema:citation https://app.dimensions.ai/details/publication/pub.1081900399
20 https://app.dimensions.ai/details/publication/pub.1082321746
21 https://doi.org/10.1016/0192-0561(83)90020-6
22 https://doi.org/10.1016/0196-9781(83)90010-4
23 https://doi.org/10.1016/0277-5379(85)90088-4
24 https://doi.org/10.1016/0304-3835(83)90087-3
25 https://doi.org/10.1016/0361-9230(84)90164-3
26 https://doi.org/10.1016/s0140-6736(78)92100-1
27 https://doi.org/10.1136/bmj.1.6058.425
28 https://doi.org/10.1159/000299028
29 https://doi.org/10.1177/030089168607200410
30 https://doi.org/10.1210/jcem-50-3-427
31 https://doi.org/10.1210/jcem-50-5-949
32 schema:datePublished 1987-12
33 schema:datePublishedReg 1987-12-01
34 schema:description Endogenous opioid peptides have been shown to be involved in the regulation of tumour growth. At present, however, no data are available about the secretion of opioid peptides in cancer patients. To draw some preliminary conclusions on opioid brain function in human neoplasms, we evaluated hypophyseal hormone responses to the administration of a met-enkephalin analogue, FK 33-824. The study included 14 patients affected by early or advanced neoplastic disease, 12 healthy subjects and 7 patients with a chronic medical illness other than cancer. FK 33-824 was given intravenously at a dose of 0.3 mg. Venous blood samples were collected at zero time, and 30, 60 and 120 min after drug administration. In each sample, PRL, GH, LH, cortisol and beta-endorphin levels were measured by RIA. In all normal subjects and in patients with non-neoplastic chronic illness, FK 33-824 induced a rise in PRL and GH levels, and a decrease in LH, cortisol and beta-endorphin. A normal endocrine response to FK 33-824 was seen in our cancer patient only, while in the other cases with tumour no hormonal changes or a paradoxical response were seen after FK 33-824. Based on the fact that an abnormal endocrine response to FK 33-824 has been described in hypothalamic-pituitary disorders, in which anomalous brain opioid activity has been demonstrated, these results suggest the existence of an altered function of the opioid system in cancer patients, the clinical importance of which remains to be determined.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N70785d6294bc499093538f3dd5ef20f8
39 Nfd68490fedc1404590f3a684c9996ec4
40 sg:journal.1017082
41 schema:name Evidence for altered opioid activity in patients with cancer
42 schema:pagination 834
43 schema:productId N395339fce46642cb95e81669a6622e7e
44 N94e2c473ace64769a85e166cf6f45c6e
45 Na4bdebb0edd24d8b820c3b081c1c1322
46 Nca9c0fad84cb411f9c8de3664f61f243
47 Ne745c280b09045cb8467544c9b8e1f1e
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015521315
49 https://doi.org/10.1038/bjc.1987.300
50 schema:sdDatePublished 2019-04-10T21:24
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N27d799ace9184b4fb2841f463709c667
53 schema:url https://www.nature.com/articles/bjc1987300
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N06bace2e3b8c4059ae465d44047e53f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Growth Hormone
59 rdf:type schema:DefinedTerm
60 N0c9d9cb934e94703ad624366911fdec1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Neoplasms
62 rdf:type schema:DefinedTerm
63 N155e06a8fb1b42efb24aaacccda43ba1 rdf:first sg:person.01354712623.20
64 rdf:rest Nb22991390deb43f482eb62a68d1c9016
65 N27d799ace9184b4fb2841f463709c667 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N2fa76af3f3b44b75ac2ebd678bf80027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name D-Ala(2),MePhe(4),Met(0)-ol-enkephalin
69 rdf:type schema:DefinedTerm
70 N3317290b714c448b910585f10c4d57cb rdf:first sg:person.01352076635.00
71 rdf:rest rdf:nil
72 N37d02437888f4860a571c084c9b83d0a rdf:first sg:person.0645550356.01
73 rdf:rest N155e06a8fb1b42efb24aaacccda43ba1
74 N395339fce46642cb95e81669a6622e7e schema:name doi
75 schema:value 10.1038/bjc.1987.300
76 rdf:type schema:PropertyValue
77 N3ba8780333544c559eaa89f0acb084d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Hydrocortisone
79 rdf:type schema:DefinedTerm
80 N4a95d42636904549a6fbca798f965787 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Female
82 rdf:type schema:DefinedTerm
83 N6ce9e2eac5fa443896bd906c0d635c6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Humans
85 rdf:type schema:DefinedTerm
86 N70785d6294bc499093538f3dd5ef20f8 schema:issueNumber 6
87 rdf:type schema:PublicationIssue
88 N7bba72f0d9624d388bcaeac103ecdcb7 rdf:first sg:person.0670035541.56
89 rdf:rest Nddaae67055234605b89bbfac0c691d9b
90 N80a3c84eee0e4e69a202ce7538a386f2 rdf:first sg:person.01217742247.17
91 rdf:rest N37d02437888f4860a571c084c9b83d0a
92 N8b47666b3bc34f23aec964c8bbfcbf34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 N942ee4ccb919451aa6cc89ffb3ffbbb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Stimulation, Chemical
97 rdf:type schema:DefinedTerm
98 N94e2c473ace64769a85e166cf6f45c6e schema:name readcube_id
99 schema:value 49f379740d75e9b39f17586e1753886b389b79f81997af10445a2848227742d0
100 rdf:type schema:PropertyValue
101 Na161c1c443984c6fa0f35d0977ea77ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Luteinizing Hormone
103 rdf:type schema:DefinedTerm
104 Na4bdebb0edd24d8b820c3b081c1c1322 schema:name nlm_unique_id
105 schema:value 0370635
106 rdf:type schema:PropertyValue
107 Nb22991390deb43f482eb62a68d1c9016 rdf:first sg:person.01365013037.39
108 rdf:rest Nd20da6ed3c34402da4fb881a5945c7e1
109 Nbf85ad1d145a40e1bbe04a2f827834bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Pituitary Gland
111 rdf:type schema:DefinedTerm
112 Nca9c0fad84cb411f9c8de3664f61f243 schema:name dimensions_id
113 schema:value pub.1015521315
114 rdf:type schema:PropertyValue
115 Nd20da6ed3c34402da4fb881a5945c7e1 rdf:first sg:person.01123521022.73
116 rdf:rest N7bba72f0d9624d388bcaeac103ecdcb7
117 Nd45fcc03521347418b87794fb3bf41e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name beta-Endorphin
119 rdf:type schema:DefinedTerm
120 Nddaae67055234605b89bbfac0c691d9b rdf:first sg:person.01371224222.07
121 rdf:rest N3317290b714c448b910585f10c4d57cb
122 Ne745c280b09045cb8467544c9b8e1f1e schema:name pubmed_id
123 schema:value 2963662
124 rdf:type schema:PropertyValue
125 Ned4209f040f345f58b920dabcd61d3b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 Nf248cbbd960544db8152db1ce33783c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Time Factors
130 rdf:type schema:DefinedTerm
131 Nf6cbd0dbe252412aaf9aad22acad8625 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Prolactin
133 rdf:type schema:DefinedTerm
134 Nf90a6769dcf649a0b20c0f990f8d5d1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Adult
136 rdf:type schema:DefinedTerm
137 Nfd68490fedc1404590f3a684c9996ec4 schema:volumeNumber 56
138 rdf:type schema:PublicationVolume
139 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
140 schema:name Medical and Health Sciences
141 rdf:type schema:DefinedTerm
142 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
143 schema:name Clinical Sciences
144 rdf:type schema:DefinedTerm
145 sg:journal.1017082 schema:issn 0007-0920
146 1532-1827
147 schema:name British Journal of Cancer
148 rdf:type schema:Periodical
149 sg:person.01123521022.73 schema:familyName Rovelli
150 schema:givenName F
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123521022.73
152 rdf:type schema:Person
153 sg:person.01217742247.17 schema:affiliation https://www.grid.ac/institutes/grid.415025.7
154 schema:familyName Lissoni
155 schema:givenName P
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217742247.17
157 rdf:type schema:Person
158 sg:person.01352076635.00 schema:familyName Tancini
159 schema:givenName G
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352076635.00
161 rdf:type schema:Person
162 sg:person.01354712623.20 schema:familyName Paolorossi
163 schema:givenName F
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354712623.20
165 rdf:type schema:Person
166 sg:person.01365013037.39 schema:familyName Crispino
167 schema:givenName S
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365013037.39
169 rdf:type schema:Person
170 sg:person.01371224222.07 schema:familyName Delitala
171 schema:givenName G
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371224222.07
173 rdf:type schema:Person
174 sg:person.0645550356.01 schema:familyName Barni
175 schema:givenName S
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645550356.01
177 rdf:type schema:Person
178 sg:person.0670035541.56 schema:familyName Ferri
179 schema:givenName L
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670035541.56
181 rdf:type schema:Person
182 https://app.dimensions.ai/details/publication/pub.1081900399 schema:CreativeWork
183 https://app.dimensions.ai/details/publication/pub.1082321746 schema:CreativeWork
184 https://doi.org/10.1016/0192-0561(83)90020-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048561010
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/0196-9781(83)90010-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012266972
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/0277-5379(85)90088-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008751506
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/0304-3835(83)90087-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018789955
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/0361-9230(84)90164-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050077684
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/s0140-6736(78)92100-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022386061
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1136/bmj.1.6058.425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042830760
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1159/000299028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015129013
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1177/030089168607200410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079551885
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1210/jcem-50-3-427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064310998
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1210/jcem-50-5-949 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064311117
205 rdf:type schema:CreativeWork
206 https://www.grid.ac/institutes/grid.415025.7 schema:alternateName Azienda Ospedaliera San Gerardo
207 schema:name Division of Radiation Oncology, Ospedale San Gerardo, Monza, Milan, Italy.
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...